Seleccione un Tamaño
Acerca de este artículo
biological source
rabbit
Quality Level
antibody form
purified antibody
antibody product type
primary antibodies
clone
SC1-1, monoclonal
species reactivity
E. coli, human
species reactivity (predicted by homology)
all
technique(s)
affinity chromatography: suitable
dot blot: suitable
immunocytochemistry: suitable
western blot: suitable
isotype
IgG
shipped in
wet ice
target post-translational modification
phosphorylation (N1-pHis)
General description
Immunogen
Application
Western Blotting Analysis: A representative lot detected heat-sensitive histidine N1-phosphorylation (1-pHis) in multiple cell lysates (Fuhs, S.R., et al. (2015). Cell. 162(1):198-210).
Immunocytochemistry Analysis: A representative lot detected N1-phosphohistidine (1-pHis) immunoreactivity distinct from that of 3-pHis in 4% paraformaldehyde-fixed HeLa cells and murine bone marrow-derived macrophages by fluorescent immunocytochemistry. The 1-pHis immunoreactivity was found in regions surrounding acidic compartments, but not inside these compartments or nuclei (Fuhs, S.R., et al. (2015). Cell. 162(1):198-210).
Immunoaffinity Purification: A representative lot was cross-linked to protein A resins for immunoaffinity purification of 1-pHis proteins from cell lysates prior to LC-MS/MS analysis (Fuhs, S.R., et al. (2015). Cell. 162(1):198-210).
Note: DO NOT HEAT SAMPLES prior to phosphohistidine detection. Histidine phosphorylation is heat and acid labile. To generate negative control for specificity test, an aliquot of sample can be heated at 95ºC for 10-15 minutes to reverse histidine phosphorylation. Alternatively, an aliquot of sample can be incubated under acidified pH at 37ºC for 15 minutes to reduce histidine phosphorylation. Acidify each 100 µL sample with 25 µL of 1 M HCl before the incubation, then neutralize with 25 µL of 1 M NaOH prior to phosphohistidine detection.
Biochem/physiol Actions
Physical form
Analysis Note
Western Blotting Analysis: 0.3 µg/mL of this antibody detected recombinant human NME1 (NM23-H1) with N1-phosphohistidine (1-pHis) in a 5 µg aliquot of autophosphorylation reaction.
Other Notes
¿No encuentra el producto adecuado?
Pruebe nuestro Herramienta de selección de productos.
Clase de almacenamiento
12 - Non Combustible Liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
A major focus of breast cancer research is to understand the mechanisms responsible for disease progression and drug resistance. Toward that end, it has been found that approximately two thirds of all human breast carcinomas overexpress the Estrogen Receptor α (ERα) protein and it remains the primary pharmacological target for endocrine therapy1,2. The normal cellular function of ERα is as a transcription factor that mediates a wide variety of physiological processes, many of which are dependent upon phosphorylation of the receptor at specific amino acid residues3,4. Indeed, ERα is known to be phosphorylated at a multitude of different sites, yet how these all correlate to disease remains unclear5. Here, we interrogated multiple sites of ERα for phosphorylation status by screening an extensive panel of different breast cancer patient samples and other non-breast cancer tissue microarray (TMA) slide samples to determine their relevance to disease.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico